Analyses of T cell-mediated immune response to a human melanoma-associated antigen by the young and the elderly

作者：Chakraborty Nitya G^*; Yadav Meeta; Dadras Soheil S; Singh Prashant; Chhabra Arvind; Feinn Richard; Kerr Phillip E; Grant Kels Jane M; Mukherji Bijay; Hegde Upendra P

来源：Human Immunology, 2013, 74(5): 640-647.

DOI：10.1016/j.humimm.2013.01.015

Elderly cancer patients are often excluded from immune-based clinical trials and therapies based on the belief that they respond poorly to tumor antigens. Using melanoma as a model and melanoma related Mart-1(27-35) epitope specific T cell receptor (TCR) engineered T cells as a tool we compared the T cell responses from young and elderly to the Mart-1(27-35) epitope, ex vivo. We also compared the natural Treg (nTreg) activities and the expression of a number of genes associated with immune response by quantitative real-time reverse Transcription Polymerase Chain Reaction (qRTPCR) in formalin fixed primary melanomas, in situ. We detected a significant difference in CD8(+) T cell response to Flu antigen (influenza matrix peptide Flu MP58-66), but the responses of the two cohorts to melanoma antigen were comparable. nTreg activities in the elderly was significantly compromised. The qPCR analyses of tissues from elderly patients revealed lower levels of Fox-P3 expression but comparable levels of expression of IL-2, IFN gamma, TNF alpha, IL-4, IL-10, IDO, and TGF beta. These findings indicate that elderly patients might be capable of responding to tumor antigens, and need not be excluded from immune-based therapies or clinical trials.

• 出版日期2013-5